The age of the
mind-machine
is here.
The future of consciousness, tracked daily.
Neurotechnology is rewriting what it means to be human — and what it means to be intelligent. We track the companies, breakthroughs, and ideas at this frontier, so you don't miss a moment of the most important shift in the history of mind.
754+
Companies tracked
across 9 categories
$18B+
VC invested
in the field globally
99+
Articles published
research & industry
Every Sunday
Weekly digest
NeuroTech Digest
"The question is no longer whether machines can think —
but whether they can learn to love."
Browse by category
View all 754 companies →Featured companies
Kernel
Research Tools
Kernel builds non-invasive neuroimaging helmets — the Flow (TD-fNIRS) and Flux (MEG) systems — designed to make high-resolution brain scanning accessible outside of hospital settings. Founded by Bryan Johnson, the company aims to democratize neuroscience research and brain measurement at scale.
MindMed
Psychedelics
MindMed is a clinical-stage psychedelic medicine company developing novel therapeutics derived from LSD, MDMA, and ibogaine analogs for neurological and psychiatric disorders. Their lead asset MM120 (LSD tartrate) has shown promising Phase 2b results for generalized anxiety disorder.
Recently added
5Blue Software
Neurotechnology ·
ABM Respiratory Care
Neurotechnology ·
Aduro
Neurotechnology ·
Aerska
Neurotechnology ·
AgeneBio
Neurotechnology ·
Alector
Neurotechnology ·
Alimetry
Neurotechnology ·
AliveCor
Neurotechnology ·
Funding spotlight
5Blue Software
Private
ABM Respiratory Care
Private
Aduro
Private
Aerska
Private
AgeneBio
Private
Alector
Private
Latest news
ABILITY NeuroTech has begun first-in-human testing of its novel BCI technology, marking a pivotal clinical milestone for the company.
Aurenar has secured $5.7M to advance its neuromodulation device targeting stroke recovery, signaling continued investor confidence in the segment.
Neuvotion announces commercialization of BCI and brain-body interface technologies, backed by a clinical study published in Nature Medicine.
FDA clears Modius Spero via De Novo pathway, marking a significant regulatory milestone for neuromodulation-based PTSD treatment.
BRYM has secured €650K in early-stage funding to develop a wearable neurofeedback platform targeting both consumer wellness and clinical applications.
European neurotech startup ReVision Implant has closed a €4 million funding round to develop its visual cortex implant technology.
Catalio-backed neuroscience startup Flourish has launched publicly with investment from Bezos Expeditions and Google Ventures.
Science Corp. has launched its Prima vision-restoring BCI implant in Europe, marking a significant commercial milestone for photovoltaic retinal technology.
Every Sunday
The NeuroTech Digest
Funding rounds, breakthroughs, and top jobs — curated weekly for industry professionals.
Subscribe free →For companies
Reach neurotech decision-makers
Premium listings, newsletter sponsorships, and featured placements.
View packages →News & insights
All articles →
ProductABILITY NeuroTech Reaches First-in-Human Milestone With Novel Brain-Computer Interface
ABILITY NeuroTech has begun first-in-human testing of its novel BCI technology, marking a pivotal clinical milestone for the company.
2026-07-30
FundingAurenar Raises $5.7M to Push Stroke Neuromodulation Device Toward Market
Aurenar has secured $5.7M to advance its neuromodulation device targeting stroke recovery, signaling continued investor confidence in the segment.
2026-07-29
ProductNeuvotion Brings Brain-Computer and Brain-Body Interface Technologies to Market as Nature Medicine Study Lands
Neuvotion announces commercialization of BCI and brain-body interface technologies, backed by a clinical study published in Nature Medicine.
2026-07-28
PolicyFDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
FDA clears Modius Spero via De Novo pathway, marking a significant regulatory milestone for neuromodulation-based PTSD treatment.
2026-07-27
FundingBRYM Raises €650K to Build Wearable Neurofeedback Platform for Consumer and Clinical Markets
BRYM has secured €650K in early-stage funding to develop a wearable neurofeedback platform targeting both consumer wellness and clinical applications.
2026-07-26
FundingReVision Implant Secures €4 Million to Advance Next-Generation Visual Neuroprosthetics
European neurotech startup ReVision Implant has closed a €4 million funding round to develop its visual cortex implant technology.
2026-07-25
The field, by the numbers
754+
Companies mapped
across 9 sectors
$18B+
VC invested
in the field globally
3×/week
News published
Mon · Wed · Fri
33+
Articles
research & industry
Companies by sector
22
Brain-Computer
11
Cognitive
29
Mental
35
Neuromodulation
31
Neuropharmaceuticals
20
Neurodiagnostics
12
Research
13
Neurofeedback
39
Psychedelics
The NeuroTech Digest
The signal through the noise — breakthroughs, funding, and ideas at the edge of mind and machine. Curated weekly.
No spam. Unsubscribe anytime.